Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: Data from the DA‐COVID‐19 registry

Global reporting of cases of COVID‐19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic

(2020) S.K. Mahil et al.   BRITISH JOURNAL OF DERMATOLOGY

Optimizing Care for Atopic Dermatitis Patients During COVID-19 Pandemic

(2020) Monica Shah et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

SARS‐CoV‐2 asymptomatic infection in a patient under treatment with dupilumab

(2020) Francesca Caroppo et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Safety of dupilumab in severe atopic dermatitis and infection of Covid‐19: two case reports

(2020) S. Ferrucci et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis

(2020) Andreas Wollenberg et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies

(2020) Federico Pirro et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic

(2020) Donovan G. Kearns et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis

(2019) Lawrence F. Eichenfield et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis

(2019) Margitta Worm et al.   JAMA Dermatology